Medicinal cannabis suite expands

By Shannon Beattie
Updated April 6 2021 - 7:09am, first published 2:00am
LGP Flower THC 22 Desert Flame is a Schedule 8 medicine, a controlled drug and is a high tetra-hydrocannabinol (THC) to cannabidiol (CBD) ratio product.

LITTLE Green Pharma (LGP) has launched its first dried flower cannabis medicine as patient demand for the product accelerates in Australia.



Get the latest Western Australia news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.